High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

Slični predmeti

• High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
  od: Mitchell, S, i dr.
  Izdano: (1997)
• Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
  od: Mitchell, SA, i dr.
  Izdano: (1997)
• High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial
  od: Bansi, D, i dr.
  Izdano: (1996)
• A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
  od: Mitchell, SA, i dr.
  Izdano: (2001)
• URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
  od: Lo, S, i dr.
  Izdano: (1992)